Check out your Company Bowl for anonymous work chats.
Cleveland HeartLab is to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.
Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
"This transaction builds on the strong relationship we've built with Hartford HealthCare, as well as providers and patients across the region who benefit from greater access to Quest's diagnostic insights and innovations," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "It is also the fifth strategically aligned, accretive acquisition we've announced in 2017, delivering on our two-point strategy to accelerate growth and drive operational excellence, while strengthening our presence in New England."
Quest Diagnostics Completes Acquisition of the Outreach Laboratory Services of Two Hartford HealthCare Hospitals in Connecticut
"By joining forces with Shiel, physicians and patients in the New York-New Jersey region will have broader access to Quest's diagnostic insights and innovations," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "The acquisition will also deliver on Quest's strategy to accelerate growth and drive operational excellence through strategically aligned, accretive acquisitions."
Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
We're supporting The National Center on Addiction and Substance Abuse's annual Family Day: Making Everyday Special initiative. Our Chairman, President and CEO, Steve Rusckowski, explains why it's so important.
A Commitment to Strong Families, Healthy Communities
Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis - Read the full release: http://glassdoor.com/slink.htm?key=vQDvo
Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis
"This new approach from Quest Diagnostics ... replaces an outmoded approach to estimating levels of the bad cholesterol, LDL. Although that method has been the standard for 45 years, it is inaccurate and misleading in many cases, especially when the patient is not fasting. The old method is being replaced with a more precise view of a patient's LDL-C, which does not require an overnight fast," said Eliot A. Brinton, M.D., FAHA, FNLA, president, Utah Lipid Center in Salt Lake City, member of the board of directors of the National Lipid Association, and past president of the American Board of Clinical Lipidology.
Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics.
"During his four and half years as President and CEO, Steve has demonstrated strong leadership, strategic vision, and an ability to drive results and get things done."
Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board
Point-of-care healthcare analytics technology Data Diagnostics, a collaboration between Quest Diagnostics and Inovalon, facilitates better care quality and value-based financial performance. We're proud of this Best in Biz award!
Data Diagnostics Named Most Innovative Healthcare Product of the Year by 2016 Best in Biz Awards
IBM Watson Health and Quest announced the launch of IBM Watson Genomics from Quest Diagnostics, a new service that helps advance precision medicine by combining cognitive computing with genomic tumor sequencing.
IBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide